| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Cytokinetics Inc | |
|---|---|
| Ticker | CYTK |
| CIK # | 0001061983 |
| CUSIP | 23282W100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 280 East Grand Avenue, South San Francisco, CA 94080 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001061983] | 10-K | |
| [0001061983] | 10-Q | |
| [0001061983] | 3 | |
| [0001061983] | 4 | |
| [0001061983] | 5 | |
| [0001061983] | 8-K | |
| [0001061983] | SC 13D | |
| [0001061983] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Callos Andrew
Common Stock
|
2026-03-31 | Sell | 3,639 | $65.00 | 236,535 |
|
Callos Andrew
Common Stock
|
2026-03-18 | Sell | 1,930 | $62.07 | 119,795 |
|
Blum Robert I
Common Stock
|
2026-03-17 | Sell | 23,928 | $62.15 | 1,487,125 |
|
Callos Andrew
Common Stock
|
2026-03-17 | Sell | 2,916 | $62.15 | 181,229 |
|
Malik Fady Ibraham
Common Stock
|
2026-03-17 | Sell | 4,397 | $62.15 | 273,274 |
|
Blum Robert I
Common Stock
|
2026-03-17 | Sell | 12,673 | $62.15 | 787,627 |
|
Lee Sung
Common Stock
|
2026-03-17 | Sell | 4,935 | $62.15 | 306,710 |
|
Callos Andrew
Common Stock
|
2026-03-17 | Sell | 5,626 | $62.15 | 349,656 |
|
Malik Fady Ibraham
Common Stock
|
2026-03-17 | Sell | 7,636 | $62.15 | 474,577 |
|
Callos Andrew
Common Stock
|
2026-03-16 | Sell | 1,709 | $61.03 | 104,300 |
|
Hessekiel Jeffrey
Common Stock
|
2026-03-15 | Grant | 20,646 | $0.00 | |
|
Blum Robert I
Incentive Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 1,665 | $0.00 | |
|
Blum Robert I
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 111,864 | $0.00 | |
|
Malik Fady Ibraham
Common Stock
|
2026-03-15 | Grant | 27,306 | $0.00 | |
|
Callos Andrew
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 29,480 | $0.00 | |
|
Callos Andrew
Incentive Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 1,665 | $0.00 | |
|
Callos Andrew
Common Stock
|
2026-03-15 | Grant | 20,646 | $0.00 | |
|
Blum Robert I
Common Stock
|
2026-03-15 | Grant | 75,258 | $0.00 | |
|
Callos Andrew
Common Stock
|
2026-03-15 | Grant | 13,320 | $0.00 | |
|
Malik Fady Ibraham
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 39,527 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 450 | 136,673,080 |
| 2025-12-31 | 438 | 126,265,155 |
| 2025-09-30 | 390 | 126,093,270 |
| 2025-06-30 | 320 | 122,608,108 |
| 2025-03-31 | 360 | 128,123,801 |
| 2024-12-31 | 353 | 122,285,869 |
| 2024-09-30 | 358 | 130,828,085 |
| 2024-06-30 | 358 | 130,499,603 |
| 2024-03-31 | 400 | 122,637,494 |
| 2023-12-31 | 369 | 128,266,863 |
| 2023-09-30 | 258 | 108,075,003 |
| 2023-06-30 | 258 | 104,396,485 |